Citations (18)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Ricardo P. Garay, Leslie Citrome, George T. Grossberg, Icilio Cavero & Pierre-Michel Llorca. (2016) Investigational drugs for treating agitation in persons with dementia. Expert Opinion on Investigational Drugs 25:8, pages 973-983.
Read now
Read now
Ricardo P. Garay, Leslie Citrome, Ludovic Samalin, Chen-Chung Liu, Morten S. Thomsen, Christoph U. Correll, Ahcène Hameg & Pierre-Michel Llorca. (2016) Therapeutic improvements expected in the near future for schizophrenia and schizoaffective disorder: an appraisal of phase III clinical trials of schizophrenia-targeted therapies as found in US and EU clinical trial registries. Expert Opinion on Pharmacotherapy 17:7, pages 921-936.
Read now
Read now
Ricardo P. Garay, Michel Bourin, Evelyne de Paillette, Ludovic Samalin, Ahcène Hameg & Pierre-Michel Llorca. (2016) Potential serotonergic agents for the treatment of schizophrenia. Expert Opinion on Investigational Drugs 25:2, pages 159-170.
Read now
Read now
Mathias Zink & Christoph U Correll. (2015) Glutamatergic agents for schizophrenia: current evidence and perspectives. Expert Review of Clinical Pharmacology 8:3, pages 335-352.
Read now
Read now
Articles from other publishers (14)
Chenyuan Du, Jiayue Chen, Xiaoyan Ma, Wenzhen Tu, Langlang Chen, Jian Liu, Dan Zhou, Xinying Chen, Jiulong Zhang, Hongjun Tian, Chuanjun Zhuo & Deguo Jiang. (2022) Testing the validity and reliability of the Chinese version of the Staden schizophrenia anxiety rating scale. Frontiers in Psychiatry 13.
Crossref
Crossref
Paula Michelotti, Francini Franscescon, Talise E. Müller, Denis B. Rosemberg & Maria E. Pereira. (2022) Ketamine acutely impairs memory consolidation and repeated exposure promotes stereotyped behavior without changing anxiety- and aggression-like parameters in adult zebrafish. Physiology & Behavior 247, pages 113708.
Crossref
Crossref
Werdie Van Staden, Antonia Dlagnekova & Kalai Naidu. (2022) Validity and Reliability of the Staden Schizophrenia Anxiety Rating Scale. Diagnostics 12:4, pages 831.
Crossref
Crossref
Akash Rathore, Vivek Asati, Sushil Kumar Kashaw, Shivangi Agarwal, Deepa Parwani, Sushanta Bhattacharya & Chaitali Mallick. (2021) The Recent Development of Piperazine and Piperidine Derivatives as Antipsychotic Agents. Mini-Reviews in Medicinal Chemistry 21:3, pages 362-379.
Crossref
Crossref
Vasilios G. Masdrakis & David S. Baldwin. (2021) Anticonvulsant and antipsychotic medications in the pharmacotherapy of panic disorder: a structured review. Therapeutic Advances in Psychopharmacology 11, pages 204512532110023.
Crossref
Crossref
Kalai Naidu, Werdie van Staden & Lizelle Fletcher. (2020) Discerning undifferentiated anxiety from syndromal anxiety in acute-phase schizophrenia. Annals of General Psychiatry 19:1.
Crossref
Crossref
Keiko Unno & Yoriyuki Nakamura. 2019. Caffeinated and Cocoa Based Beverages. Caffeinated and Cocoa Based Beverages
209
234
.
Sana Sarfraz, Sidra khan, Zarnab Augustine, Hira Raees, Rabia Arif & Kiran Saeed. (2018) Anxiolytic activity of tomato juice on animal model. Journal of Analytical & Pharmaceutical Research 7:2.
Crossref
Crossref
L. Moulédous, P. Roullet & Bruno P. Guiard. 2018. 5-HT2A Receptors in the Central Nervous System. 5-HT2A Receptors in the Central Nervous System
231
258
.
Baptiste Pignon, Chloé Tezenas du Montcel, Louise Carton & Antoine Pelissolo. (2017) The Place of Antipsychotics in the Therapy of Anxiety Disorders and Obsessive-Compulsive Disorders. Current Psychiatry Reports 19:12.
Crossref
Crossref
Fleur M. Howells, David G. Kingdon & David S. Baldwin. (2017) Current and potential pharmacological and psychosocial interventions for anxiety symptoms and disorders in patients with schizophrenia: structured review. Human Psychopharmacology: Clinical and Experimental 32:5, pages e2628.
Crossref
Crossref
Ei Terasawa & Jon E. Levine. 2017. Hormones, Brain and Behavior. Hormones, Brain and Behavior
309
356
.
Artur Palasz, Ewa Rojczyk, Milosz Golyszny, Lukasz Filipczyk, John J. Worthington & Ryszard Wiaderkiewicz. (2015) Long-term treatment with haloperidol affects neuropeptide S and NPSR mRNA levels in the rat brain. Acta Neuropsychiatrica 28:2, pages 110-116.
Crossref
Crossref
Henk Temmingh & Dan J. Stein. (2015) Anxiety in Patients with Schizophrenia: Epidemiology and Management. CNS Drugs 29:10, pages 819-832.
Crossref
Crossref